Galapagos NV (OTC Pink - Current Information:GLPYY)

Data as of Sep 10
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. The company operates through two operating divisions: Research and Development and Services. The Research and Development division develops medicines based on novel mode-of-action. The Service division offers target-to-drug discovery products and services to pharmaceutical and biotech companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates. The company was founded by Onno van de Stolpe and Rudi Pauwels in 1999 and is headquartered in Mechelen, Belgium.

Contact Information

Galapagos NV
Industriepark Mechelen Noord
Mechelen -- 2800
P:(321) 534-2900
Investor Relations:
(262) 291-6240



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Onno van de StolpeChief Executive Officer & Executive Director
Guillaume JettenChief Financial Officer
Piet WigerinckChief Scientific Officer
Andre HoekemaSenior Vice President-Corporate Development
Radan SpaventiSenior Vice President-Internal Outsourcing

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.